{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:48:48Z","timestamp":1793116128689,"version":"4.5.0"},"reference-count":21,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2022,3,16]]},"abstract":"<jats:p>The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is an international susceptibility testing committee, organized by the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) and functioning as the breakpoint advisory committee of the European Medicines Agency (EMA). The original remit of EUCAST was to harmonize European clinical breakpoints, but very soon, the activities expanded beyond the borders of Europe and included newly licensed agents in Europe.<\/jats:p>","DOI":"10.1128\/jcm.00276-21","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T11:52:18Z","timestamp":1628077938000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":196,"title":["Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)"],"prefix":"10.1128","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-6122","authenticated-orcid":true,"given":"Christian G.","family":"Giske","sequence":"first","affiliation":[{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4240-5578","authenticated-orcid":true,"given":"John","family":"Turnidge","sequence":"additional","affiliation":[{"name":"Adelaide Medical School and School of Biological Sciences, University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-3173","authenticated-orcid":true,"given":"Rafael","family":"Cant\u00f3n","sequence":"additional","affiliation":[{"name":"Servicio de Microbiolog\u00eda, Hospital Universitario Ram\u00f3n y Cajal and Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria (IRYCIS), Madrid, Spain"},{"name":"CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Kahlmeter","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Central Hospital, V\u00e4xj\u00f6, Sweden"},{"name":"The EUCAST Development Laboratory, EUCAST, V\u00e4xj\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg312"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv145"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2015.20.2.21008"},{"key":"e_1_3_2_5_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. EUCAST general website. www.eucast.org."},{"key":"e_1_3_2_6_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. EUCAST public consultations. https:\/\/www.eucast.org\/publications_and_documents\/consultations\/."},{"key":"e_1_3_2_7_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. EUCAST clinical breakpoint table. https:\/\/www.eucast.org\/clinical_breakpoints\/."},{"key":"e_1_3_2_8_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2007. SOP between EMA and EUCAST describing the role of EUCAST in determining breakpoints. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/4ESCMID_Library\/3Publications\/EUCAST_Documents\/Other_Documents\/EMEA_CHMP_EUCAST_SOP_on_Harmonising_European_Breakpoints_2007.pdf."},{"key":"e_1_3_2_9_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2016. EUCAST statutes. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/EUCAST_Statutes_20160411_approved_by_General_Committee.pdf."},{"key":"e_1_3_2_10_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2019. The organization of national antimicrobial susceptibility testing committees (NAC). https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/General_documents\/Organisation_and_NACs\/NACs_2019__1_.docx."},{"key":"e_1_3_2_11_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. EUCAST Rationale Documents. https:\/\/www.eucast.org\/publications_and_documents\/rd\/."},{"key":"e_1_3_2_12_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. Calibration of zone diameter breakpoints against MIC values. https:\/\/www.eucast.org\/ast_of_bacteria\/calibration_and_validation\/."},{"key":"e_1_3_2_13_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. The EUCAST Subcommittee on MIC distributions and ECOFFs. https:\/\/www.eucast.org\/organization\/subcommittees\/mic_distributions_and_ecoffs\/."},{"key":"e_1_3_2_14_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. Display of MIC and inhibition zone diameter distributions and ECOFFs. https:\/\/mic.eucast.org. Accessed 2 May 2021."},{"key":"e_1_3_2_15_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2019. MIC distributions and the setting of epidemiological cutoff (ECOFF) values. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/EUCAST_SOPs\/2021\/EUCAST_SOP_10.2_MIC_distributions_and_epidemiological_cut-off_value__ECOFF__setting_20211202.pdf."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00115-20"},{"key":"e_1_3_2_17_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2020. Guidance document on broth microdilution testing of cefiderocol. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Guidance_documents\/Cefiderocol_MIC_testing_EUCAST_guidance_document_201217.pdf."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Bhavnani SM Onufrak NJ Hammel JP Andes DR Bradley JS Flamm RK Ambrose PG Jones RN. 2018. Re-appraisal of aminoglycoside (AG) susceptibility testing breakpoints based on the application of pharmacokinetics-pharmacodynamics (PK-PD) and contemporary microbiology surveillance data. Poster No. 2562. IDWeek San Francisco CA 3 to 7 October 2018.","DOI":"10.1093\/ofid\/ofy209.170"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12163"},{"key":"e_1_3_2_20_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2020. EUCAST fosfomycin consultation document. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Consultation\/2020\/EUCAST_General_Consultation_on_Fosfomycon_trometamol_2020.pdf."},{"key":"e_1_3_2_21_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. EUCAST warnings. https:\/\/www.eucast.org\/ast_of_bacteria\/warnings\/."},{"key":"e_1_3_2_22_2","unstructured":"European Committee on Antimicrobial Susceptibility Testing. 2021. EUCAST newsletter signup. https:\/\/www.eucast.org\/eucast_news\/."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00276-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00276-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T10:02:34Z","timestamp":1647424954000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.00276-21"}},"subtitle":[],"editor":[{"given":"Romney M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,16]]}},"alternative-id":["10.1128\/jcm.00276-21"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00276-21","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]},"assertion":[{"value":"2022-03-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00276-21"}}